LWMG LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$942K Buy
1,063
+15
+1% +$13.5K 0.18% 39
2024
Q2
$948K Buy
1,048
+34
+3% +$27.2K 0.2% 36
2024
Q1
$789K Sell
1,014
-92
-8% -$65.5K 0.18% 39
2023
Q4
$645K Sell
1,106
-21
-2% -$12.3K 0.16% 43
2023
Q3
$605K Buy
1,127
+1
+0.1% +$515 0.17% 44
2023
Q2
$528K Sell
1,126
-15
-1% -$6.29K 0.15% 48
2023
Q1
$392K Sell
1,141
-32
-3% -$10.8K 0.12% 58
2022
Q4
$429K Buy
+1,173
New +$416K 0.15% 63

Other funds holding LLY

LWMG LLC's LLY Position: Q3 2024 in Review

LWMG LLC increased its Eli Lilly (LLY) stake by 1.4% in Q3 2024, buying an estimated $13.5K and bringing the position to 1,063 shares worth $942K. The position accounts for 0.18% of the portfolio, ranked #39.

LWMG LLC first reported a position in LLY in Q4 2022 and has held it in 8 quarters since. The position peaked at $948K in Q2 2024. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • LWMG LLC held 1,063 shares of Eli Lilly worth $942K as of Q3 2024.
  • LWMG LLC bought 15 Eli Lilly shares in Q3 2024, an estimated $13.5K.
  • Eli Lilly made up 0.18% of LWMG LLC's portfolio in Q3 2024, its #39 holding.
  • LWMG LLC first reported a position in Eli Lilly in Q4 2022 and has held it in 8 quarters since.
  • LWMG LLC's Eli Lilly position peaked at $948K in Q2 2024.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on LWMG LLC's 13F filing for Q3 2024, filed 4 Oct 2024.